This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Ketoconazole

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Indications:

  • systemic mycosis
  • serious chronic resistant mucocutaneous candidiasis
  • serious resistant gastrointestinal mycosis
  • chronic resistant vaginal candidiasis
  • resistant dermatophyte infections of skin or fingernails
  • prophylaxis against mycosis in immunosuppressed patients
  • pituitary Cushing's disease

Cautions:

  • avoid in porphyria
  • pregnancy
  • beware interactions - See current issue of BNF

Contra-indications:

  • hepatic impairment

Side-effects:

  • nausea
  • pruritus
  • rashes
  • fatal liver damage - See current issue of BNF
  • up to 25% of patients have abnormal liver function tests

Routes of administration:

  • oral:
    • tablets
    • suspension
  • topical preparations are also available e.g. shampoo

MRHA guidance states:

  • Oral ketoconazole should no longer be prescribed or used for fungal infections
  • Doctors should review patients who are taking this medicine for a fungal infection, with a view to stopping treatment or choosing an appropriate alternative
  • Pharmacists should refer patients with a prescription of oral ketoconazole for treatment of a fungal infection to their treating doctor for a non-urgent appointment to discuss suitable alternative treatments
  • Topical ketoconazole formulations (such as creams, ointments, and shampoos) have very low systemic absorption and may continue to be used as currently approved
  • Ketoconazole is sometimes used off-label for patients with Cushing's syndrome. Arrangements are being put in place to ensure this group of patients continue to have access to oral ketoconazole

The summary of products characteristics must be consulted before prescribing this drug.

Reference:

  • MRHA (August 1st 2013). Oral ketoconazole: do not prescribe or use for fungal infections - risk of liver injury outweighs benefits

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.